CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net earnings		$ 396,835	$ 392,340	$ 334,621
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization		249,681	238,625	223,834
Impairment losses – real estate, net of recoveries		6,632	5,990	8,309
Amortization of notes payable discount		2,926	2,074	1,691
Amortization of debt costs		5,993	4,943	4,734
Amortization of mortgages payable premium		0	(21)	(87)
Amortization of interest rate hedges		2,152	2,471	2,374
Gain on disposition of real estate		(42,290)	(47,485)	(17,443)
Performance incentive plan expense		12,835	13,375	17,330
Performance incentive plan payment		(1,274)	(916)	(103)
Change in operating assets and liabilities, net of assets acquired and liabilities assumed:
Decrease (increase) in receivables		674	(853)	358
Decrease (increase) in accrued rental income		(294)	(7,453)	3,559
Decrease in other assets		(190)	243	424
Increase (decrease) in accrued interest payable		(4,675)	10,548	(97)
Increase (decrease) in other liabilities		6,581	(1,550)	(1,217)
Other		(82)	79	68
Net cash provided by operating activities		635,504	612,410	578,355
Cash flows from investing activities:
Proceeds from the disposition of real estate		149,834	116,334	66,962
Additions to real estate		(572,874)	(795,791)	(842,872)
Principal payments received on mortgages and notes receivable		599	559	521
Other		(1,895)	(1,762)	(2,242)
Net cash used in investing activities		(424,336)	(680,660)	(777,631)
Cash flows from financing activities:
Proceeds from line of credit payable		545,500	872,500	688,000
Repayment of line of credit payable		(677,500)	(906,700)	(521,800)
Repayment of mortgages payable		0	(9,947)	(664)
Proceeds from notes payable		493,840	488,380	0
Repayment of notes payable		(350,000)	0	0
Payment of debt issuance costs		(13,127)	(4,510)	(199)
Proceeds from issuance of common stock		217,581	32,328	253,972
Stock issuance costs		(3,316)	(966)	(3,761)
Payment of common stock dividends		(420,239)	(404,458)	(380,538)
Noncontrolling interest distributions		0	0	(278)
Net cash provided by (used in) financing activities		(207,261)	66,627	34,732
Net decrease in cash, cash equivalents and restricted cash		3,907	(1,623)	(164,544)
Cash, cash equivalents and restricted cash at beginning of year	[1]	5,155	6,778	171,322
Cash, cash equivalents and restricted cash at end of year	[1]	9,062	5,155	6,778
Supplemental disclosure of cash flow information:
Interest paid, net of amount capitalized		183,426	148,169	140,331
Supplemental disclosure of noncash investing and financing activities:
Change in other comprehensive income		2,152	2,471	2,374
Right-of-use assets recorded in connection with lease liabilities		0	6,401	0
Change in work in progress accrual		$ (7,458)	$ 23,103	$ 4,468

[1] Cash, cash equivalents and restricted cash is the aggregate of cash and cash equivalents and restricted cash and cash held in escrow from the Consolidated Balance Sheets. As of December 31, 2024, 2023 and 2022, NNN had restricted cash of $331, $3,966 and $4,273, respectively.